Zerila Therapeutics News | Page 3 of 7 | Cannabiz

Zelira

Zelira publishes positive results from autism study

by Martin Lane May 18, 2022April 29, 2024

Zelira Therapeutics has published positive results from an observational trial of its Hope cannabinoid medicine for […]

Company news: Incannex; Emyria; Creso Pharma; Zelira; MGC Pharma

by Martin Lane May 11, 2022April 29, 2024

Long-serving AFL coach Damien Hardwick joins Levin Health’s sports advisory board

by Martin Lane May 9, 2022April 29, 2024

Cronos to explore further acquisitions as merged group reports A$3.4m profit

by Steve Jones February 26, 2022April 29, 2024

Zelira to acquire medicinal cannabis distributor Health House International

by Steve Jones February 24, 2022April 29, 2024

Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex

by Martin Lane February 2, 2022April 29, 2024

Company news: ECS Botanics: Zelira; InhaleRx; Emyria; Rua Bioscience; MJBiz

by Martin Lane January 13, 2022April 29, 2024

Zelira

Zelira expands into New Zealand

by Martin Lane December 17, 2021April 29, 2024

Company news: ANTG; Avecho; Canopy Growth; Zelira/Levin Health; Neurotech; Epsilon; Creso Pharma

by cannabiz team December 9, 2021April 29, 2024

Company news: Montu; Live Verdure; AusCann; Cann Global; MediPharm Labs; Zelira; Canopy Growth

by Martin Lane November 4, 2021April 29, 2024